CI

Cowen Investment Management

North America, New York, United States, New York

Description

Sustainable Private Equity and Credit Investments

Investor Profile

Cowen Investment Management has made 22 investments, with 0 in the past 12 months and 5% as lead.

Stage Focus

  • Post Ipo Equity (64%)
  • Series B (9%)
  • Post Ipo Debt (9%)
  • Series C (5%)
  • Series A (5%)
  • Convertible Note (5%)
  • Series D (5%)

Country Focus

  • United States (82%)
  • Canada (9%)
  • France (5%)
  • United Kingdom (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Oncology
  • Genetics
  • Clinical Trials
  • Energy
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cowen Investment Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Jennison Associates
North America, New York, United States, New York
Co-Investments: 3
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 3

Which angels does Cowen Investment Management often collaborate with?

BN
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Cowen Investment Management?

LeddarTech

Quebec, Quebec, Canada

LeddarTech is an automotive solutions company that solves critical fusion and perception challenges for all levels of autonomy.

AutomotiveAutonomous VehiclesSoftwareSoftware Engineering
Series DFeb 3, 2022
Amount Raised: $116,000,000
erytech

Lyon, Rhone-Alpes, France

ERYtech Pharma is a biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.

BiopharmaBiotechnologyHealth CareMedicalOncology
Post Ipo EquitySep 21, 2020
G1 Therapeutics

Durham, North Carolina, United States

G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology.

BiotechnologyDeveloper PlatformMedicalOncologyTherapeutics
Post Ipo EquitySep 21, 2018
Amount Raised: $195,100,000
Allogene Therapeutics

South San Francisco, California, United States

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

BiotechnologyHealth DiagnosticsOncologyPharmaceutical
Convertible NoteSep 7, 2018
Amount Raised: $120,000,000
Spero Therapeutics

Cambridge, Massachusetts, United States

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

BiotechnologyMedical DeviceTherapeutics
Post Ipo EquityJul 17, 2018
Amount Raised: $75,000,000
Tellurian

Houston, Texas, United States

Tellurian is an oil and gas exploration and production company that trades liquefied natural gas cargoes globally.

EnergyOil and GasRetail
Post Ipo EquityJun 25, 2018
Amount Raised: $115,100,000
Canopy Growth

Smiths Falls, Ontario, Canada

Canopy Growth is a cannabis consumer product company that manufactures medical cannabis to improve lives.

CannabisHealth CareMedicalPharmaceutical
Post Ipo DebtJun 21, 2018
Amount Raised: $375,402,150
Boston Omaha

Omaha, Nebraska, United States

Boston Omaha operate three separate lines of business: outdoor billboards, surety insurance and related brokerage activities.

AdvertisingInsuranceReal Estate
Post Ipo EquityMar 20, 2018
Amount Raised: $76,890,000
Kura Oncology

La Jolla, California, United States

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

BiopharmaBiotechnologyGeneticsHealth CareMedicalOncologyPrecision Medicine
Post Ipo EquityMar 12, 2018
VirnetX

Zephyr Cove, Nevada, United States

VirnetX is an internet security software and technology company that provides technology for 4G long term evolution (LTE) security.

BlockchainCyber SecurityEnterprise SoftwareInformation TechnologyInternetSecuritySoftware
Post Ipo EquityMar 9, 2018
Amount Raised: $15,000,000